Last week, Hyderabad-based Mapmygenome made headlines by acquiring Microbiome Insights, a Canadian company known for its cutting-edge work in microbiome research. With this move, Mapmygenome isn’t just expanding into a new scientific frontier—it is entering the North American market and staking a claim in the global race to harness the power of the human microbiome. The acquisition gives the company access to a CAP-accredited lab, intellectual property, and a client base that spans hundreds of studies across academia, biotech, and clinical care.
Read More